Collegium Pharmaceutical, Inc. COLL

22.53 (0.11) (0.49%) as of 25 Sep
Market cap
$737.1M
P/E
14.7×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
406.53 187.76 310.55 173.69 186.43 174.12 170.02 146.63 118.70 153.23
Receivables
211.33 228.54 179.53 183.12 105.84 83.32 72.95 77.95 9.97 2.13
Inventory
40.91 35.56 32.33 46.50 17.39 15.61 9.64 7.82 1.81 1.32
Total current assets
691.41 482.26 537.60 419.99 315.54 277.89 255.72 237.51 133.48 158.58
Property, Plant, Equpment (Net)
12.01 14.33 15.98 19.52 19.49 18.99 11.85 9.27 1.83 1.04
Goodwill and Intangible Assets (Total)
815.44 1,053.74 555.57 701.16 268.72 335.90 29.50 44.26 — 2.10
Long Term Assets (Tax, Deferred)
112.54 98.03 26.26 23.95 78.04 — — — — —
Long-term assets (Other)
21.25 9.42 1.87 2.65 2.63 2.67 0.18 0.20 0.26 0.30
Total non-current assets
965.42 1,181.33 605.71 754.14 376.53 365.95 50.58 53.73 2.08 3.44
Total Assets
1,656.83 1,663.59 1,143.31 1,174.13 692.08 643.84 306.30 291.25 135.57 162.02
Accounts Payable
10.66 3.93 8.69 3.49 4.19 10.02 6.25 12.15 5.68 9.11
Accrued Expenses
380.73 410.77 264.90 266.62 226.21 181.21 191.03 175.33 24.33 8.88
Current Part of Debt
29.00 64.58 183.33 162.50 48.35 47.50 3.83 1.64 1.48 2.67
Current Revenue (Deferred)
0.67 — — — — — — — — 4.94
Other current liabilities
17.57 28.96 — 267.00 226.00 181.00 191.00 175.00 24.33 13.82
Total current liabilities
440.03 509.51 457.92 433.73 279.57 239.45 201.77 189.13 31.49 25.60
Long Term Debt (Total)
780.33 787.91 483.84 538.45 201.63 209.59 7.67 9.86 — 1.48
Non-current Revenue (Deferred)
9.11 10.00 — — — — — — — —
Non-current Liabilities (Other)
121.56 121.80 — — — 0.00 0.00 0.68 — 0.03
Total non-current liabilities
915.13 925.24 489.96 545.56 209.58 218.36 17.11 10.53 — 1.51
Total liabilities
1,355.16 1,434.75 947.88 979.29 489.15 457.81 218.87 199.66 31.49 27.11
Additional Paid In Capital
624.95 590.25 565.95 538.07 502.10 519.14 447.30 428.73 402.10 358.06
Common Stock (Net)
0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03
Retained Earnings
(101.13) (164.00) (233.19) (281.34) (256.34) (333.15) (359.90) (337.18) (298.05) (223.18)
Treasury Stock
222.51 197.51 137.38 61.92 42.86 — — — — —
Common Equity (Total)
301.68 228.84 195.43 194.84 202.93 186.03 87.43 91.59 104.08 134.91
Shareholders Equity (Total)
301.68 228.84 195.43 194.84 202.93 186.03 87.43 91.59 104.08 134.91
Shareholders Equity and Liabilities (Total)
1,656.83 1,663.59 1,143.31 1,174.13 692.08 643.84 306.30 291.25 135.57 162.02
Shares (Common)
31.71 31.44 31.87 33.85 33.66 34.61 33.68 33.27 32.77 29.36
Shareholders Equity (Tangible)
(513.76) (824.89) (360.13) (506.32) (65.79) (149.87) 57.93 47.33 104.08 132.81
Net Debt
402.80 664.73 356.62 527.26 63.56 82.97 (158.52) (135.13) (117.22) (149.08)
Total Debt
809.33 852.49 667.17 700.95 249.99 257.09 11.50 11.50 1.48 4.15

Fold the line items

In millions of $ except per-share values · columns are period end dates